8 news items
Veru to Present at the American Diabetes Association's 84th Scientific Sessions
VERU
10 Jun 24
"forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, express
Veru to Present at the Jefferies Global Healthcare Conference
VERU
22 May 24
statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, express or implied
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
VERU
8 May 24
in the Private Securities Litigation Reform Act of 1995, including, without limitation, express or implied statements related to whether and when
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
VERU
1 May 24
release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
VERU
30 Apr 24
StatementsThis press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act
b81yzjygwwrt0s 6vxjp5nq9
VERU
25 Apr 24
contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without
iwvssk47g8wbokk42sxw2
VERU
1 Apr 24
release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including
jt78uiia4 6smotxyklcwgcfbaz5m
VERU
22 Mar 24
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995
- Prev
- 1
- Next